Journal ArticleDOI
Preoperative assessment of hilar cholangiocarcinoma using multidetector-row CT: correlation with histopathological findings.
TLDR
Investigation of the diagnostic reliability of multidetector-row computed tomography for preoperative assessment of local tumoral spread in hilar cholangiocarcinoma found it likely to play an important role in evaluation of focal lesion spread especially in intrapancreatic tumor invasion.Abstract:
Purpose
Our aim was to investigate the diagnostic reliability of multidetector-row computed tomography (MDCT) for preoperative assessment of local tumoral spread in hilar cholangiocarcinoma.read more
Citations
More filters
Journal ArticleDOI
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.
TL;DR: Magnetic resonance imaging/magnetic resonance cholangiopancreatography, positron emission tomography scan, endoscopic ultrasound and computed tomography scans are the most frequently used modalities for diagnosis and tumor staging.
Journal ArticleDOI
Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis.
TL;DR: Diagnostic accuracy studies of CT, MRI, ultrasound or PET/CT for staging of hilar cholangiocarcinoma are sparse and have moderate methodological quality, but primarily concern CT, which has an acceptable accuracy for assessment of ductal extent, portal vein and hepatic artery involvement, but low sensitivity for nodal status.
Journal ArticleDOI
Hilar cholangiocarcinoma: diagnosis, treatment options, and management.
TL;DR: Due to the complexity of this disease, a multi-disciplinary approach with multimodal treatment is recommended for this complex disease.
Journal ArticleDOI
Surgical strategy for bile duct cancer: Advances and current limitations
TL;DR: Recent advances and topics in the surgical management of bile duct cancer are described, with radical resection with a microscopically negative margin (R0) the only way to cure cholangiocarcinoma and is associated with marked survival advantages compared to margin-positive resections.
Journal ArticleDOI
Perioperative Management of Hilar Cholangiocarcinoma
TL;DR: Current management of hilar cholangiocarcinoma depends on extent of the tumor at presentation and includes surgical resection, liver transplantation, portal vein embolization, and chemoradiation therapy.
References
More filters
Journal ArticleDOI
Management strategies in resection for hilar cholangiocarcinoma.
TL;DR: Improved survival in hilar cholangiocarcinoma can be achieved by resection, with minimal morbidity and zero mortality rates, if histologically free resection margins are obtained.
Journal Article
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver
Henri Bismuth,M B Corlette +1 more
TL;DR: It is important to expand the indications for resection of tumors of the hilas, generally requiring associated hepatectomy, after careful search for metastases and biopsy of any suspicious areas makes this reasonable.
Journal ArticleDOI
Lymph Node Metastasis from Hilar Cholangiocarcinoma: Audit of 110 Patients Who Underwent Regional and Paraaortic Node Dissection
Yuichi Kitagawa,Masato Nagino,Junichi Kamiya,Katsuhiko Uesaka,Tsuyoshi Sano,Hideo Yamamoto,Naokazu Hayakawa,Yuji Nimura +7 more
TL;DR: The fact that long-term survival is possible despite pN2 or pM1 disease encourages the authors to perform an aggressive surgical procedure with extended lymph node dissection in selected patients with hilar cholangiocarcinoma.
Journal ArticleDOI
Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria.
Ho Yun Lee,Se Hyung Kim,Jeong Min Lee,Sun-Whe Kim,Jin-Young Jang,Joon Koo Han,Byung Ihn Choi +6 more
TL;DR: Combined interpretation of CT and direct cholangiographic images by using revised criteria for unresectable tumor evaluation resulted in overall accuracy of 74.5% for prediction of resectability for hilar cholangsiocarcinoma.
Journal ArticleDOI
Cholangiocarcinoma: delayed CT contrast enhancement patterns.
TL;DR: Delayed tumoral contrast enhancement is a typical feature of intrahepatic cholangiocarcinoma and may aid in the detection and characterization of such lesions at CT.